ºÝºÝߣ

ºÝºÝߣShare a Scribd company logo

About krishgen

•Download as PPSX, PDF•
•
K
Kalpesh Jain

Krishgen is an Indian biotech company established in 2003 that focuses on medical diagnostics, drug discovery research, biopharmaceuticals, and plant/food sciences. It has experienced strong growth, with revenues reaching $5 million in 2011. Krishgen provides immunoassay kits, human cell lines, glycobiology tools, and preclinical toxicology products to support research and drug development.

1 of 18
Download to read offline
We Deliver More ™ Changing India’s biotech landscape by developing tools for the life sciences and agri industry D & B / SMERA Rated
We are a single owner firm established in 2003, located in the commercial hub of India – Mumbai or erstwhile Bombay. KRISHGEN today operates in the broad segments of medical diagnostics, drug discovery research, biopharmaceuticals and plant / food sciences. The compounded average growth in the past three years has been 74% p.a. KRISHGEN gross revenues as of 2011 were USD5,0 million. A KRISHGEN PRESENTATION © 2011
HOW TO USE THIS GUIDE: About KRISHGEN Targeting the research and diagnostics markets, our goal is to enable breakthroughs in biological research, diagnostics, drug discovery and the treatment of disease. We enjoy a dominant position in the provision of immunoassay kits, supply of primary human cells and cell lines, glycobiology and preclinical toxicology tools. KRISHGEN takes a highly collaborative approach to business relationships with its customers and partners. We are committed to providing our customers with world-class solutions, service and support. Our track record of delivering innovative new products, by distribution arrangements with leading companies worldwide or the judicious interface with the academia has given us the broadest range of products available. The strength lies in our ability to understand technologies and support the scientists with technical backup and strong logistics. A KRISHGEN PRESENTATION © 2011
About KRISHGEN KRISHGEN meets the needs of its pharmaceutical and clinical customers by providing a range of Research Use Only kits for researchers in drug development and pre-clinical studies, and in offering fully-optimized and validated products for ensuing preclinical and clinical studies. KRISHGEN’s recently released cytokine ELISA kits are an innovative cost effective tool for disease research, drug discovery & development, and molecular diagnostic test development. KRISHGEN is funded privately through its owners and private investors. It is a non-listed, non-traded SME, rated by Dun & Bradstreet / SMERA (SME Rating Agency of India). Our DUNS Number is 65-039-6034. A KRISHGEN PRESENTATION © 2011
Our History To support it's plans, Krishgen initially focused on developing marketing and distribution support for diagnostics. 2004.. First Partner for distribution tied-up with Medipan GmbH / Generic Assays GmbH in Germany. 2005 .. the research and life sciences products were introduced with its arrangements with leading US & European companies. 2006 .. the Glycobiology line was introduced in October for distribution. 2007 .. the tools for preclinical toxicology were introduced in August. 2008 .. Promocell GmbH, Germany distribution started in India. Its own products under the KRISHGEN label were manufactured and introduced in October. Krishgen started offering immunoassay development services in Nov 2008. 2009 .. KRIBIOLISA bioprocess ELISA kits launched. 2010 .. KRISHILISA GMO ELISA kits and Gold Ring Cytokine ELISAs launched. 2011 .. International distribution efforts started. KRISHGEN's product and service are now used by respected academic, biotech, pharmaceutical and government laboratories in India and worldwide. A KRISHGEN PRESENTATION © 2011
KRISHGEN BIOSYSTEMS – Group Holding Proprietary Company Revenues* 2011 USD 5,0million Focuses on diagnostics, drug discovery research, plant / agri sciences and food safety Kodon Sciences KRISHTECH Solutions (India) Kodon Sciences (India) – focuses on plant sciences and food safety assays. Established in 2008. KRISHTECH Solutions – focuses on biopharmaceutical and vaccine manufacturing companies. Established in 2009. A KRISHGEN PRESENTATION © 2011
Advisory Team Raman Jain, MSc (Northwestern University, US) Over 38 years experience in healthcare industry. Previously Managing Director, Nirlac Chemicals and then Fortex Remedies Pvt Ltd, contract manufacturer of sterile pharmaceuticals. Member : Indian Pharmaceutical Association. Founder Member Indian Drug (Pharmaceutical) Manufacturers Association Kawar Prashant Govindrao Scientist (PMB), Molecular Biology & Genetic Engineering Lab., Vasantdada Sugar Institute, Pune Dr I Khatkhatay Senior Scientist, National Institute For Research in Reproductive Health, Mumbai Dr Meena Desai Scientist, National Institute For Research in Reproductive Health, Mumbai Aditya Jain, MBA (Drexel University, USA) Vice President, LaReina Collection, Los Angeles, USA. A KRISHGEN PRESENTATION © 2011
Investors / Source of Funds  Bank Of India  Owner’s Seed Capital Private Investors :  Veerchand Manawat Family  Kalpesh Jain HUF A KRISHGEN PRESENTATION © 2011
Business Concept KRISHGEN believes in professionalism. Right from choosing principals which we have done with great care to our sales channel partners or our marketing team we have applied one principle – the approach and professionalism of the entity to the job at hand. We believe that a systematic approach and focus to the job will ensure that all set targets and goals are achieved. No fancy management jargons but a simple approach of doing the job given sincerely and keeping the customer happy. Our philosophy – We Deliver More – encompasses all that we believe in. A KRISHGEN PRESENTATION © 2011
Our Sales Network We currently hold distribution rights for sales in South East Asia as well as in countries including Singapore, Malaysia, Thailand, Vietnam, Philippines for a number of our principal companies. Our focus the past few years has been in India which is our principal market and the major revenue earner. We reach the entire Indian region with our own employee based marketing field team supported by our product executives and application specialists. KRISHGEN also now has a network of distributors all across the world for its own manufactured / branded products. It also supplies on OEM labeling to leading US and Canadian based companies. A KRISHGEN PRESENTATION © 2011
Technical Sales & Marketing Support  Regular Literatures and mailing on specific products and applications. (we use Constant Contact email marketing tool)  CD presentations on Product Category Focus  Training of Technicians / Users at our application laboratory  Participation in Trade Shows, Conferences, Exhibitions  Conducting Roadshows A KRISHGEN PRESENTATION © 2011
Resources Library We have the largest resources library for marketing our products in terms of flyers, catalogs, brochures, technical series mails etc. Our in- house print shop has capacity to print and mail over 10,000 copies per month which we use in conjunction with our database. Promotions & Offers We conduct regular promotions and seasonal offers to boost sales and highlight products. A KRISHGEN PRESENTATION © 2011
Markets and Achievements KRISHGEN today holds over 80% of the market for biopharmaceuticals with its glycosylation tools working with world’s leading companies. With our focus on costs and services, we are a `strategic vendor’ and ‘preferred partner’ to a number of leading biopharma and vaccine companies. We were the first movers to market exclusively Invitrogen’s primary human cell cultures and medias (erstwhile Cascade Biologics)in India from 2004 till 2008 when Invitrogen Corporation, USA set up it’s own subsidiary in India. We hold over 74% market share for the ADME Tox in India with our nearest competitor being BD Biosciences and Invitrogen. We are the market leaders in India for Vitamin D assays for medical diagnostics and for immunoassay tools for diabetes research and clinical studies. We have developed and now market exclusively our own manufactured bioprocess contamination kits for the Indian biopharmaceutical sector as well as a host of products. A KRISHGEN PRESENTATION © 2011
Our Certifications We are registered with our Food & Drug Administration Ministry of Animal Husbandry Ministry of Health & Family Welfare Director-General of Foreign Trade Dun & Bradstreet / SMERA Our Association Memberships Member – Indian Merchant Chambers Member – Indo German Chamber of Commerce Member – Association of Biotechnology Led Enterprises Member - National Seed Association of India A KRISHGEN PRESENTATION © 2011
Scientific Presentations Posters Presented - 2009 Immunocon, Bangalore Development and validation of a generic E.coli HCP ELISA for determination of host cell proteins for biopharmaceuticals expressed in E.coli 2010 Bangalore India Bio, Bangalore Development and validation of cost effective assay for Development and validation of ELISA for qualitative assessment of Cry 2Ab protein in Bt Cotton Development and analytical validation of a generic ELISA kit for measurement of Host Cell Proteins in Chinese Hamster Ovary cells. Use of indigenous ELISA for estimation of cytokines and estradiol levels in women A KRISHGEN PRESENTATION © 2011
A KRISHGEN PRESENTATION © 2011
Our 3 E’s of Business which has enabled us to make KRISHGEN, India’s leading biotech company with products presence in Enthusiasm major markets across the world. Enterprise Energy A KRISHGEN PRESENTATION © 2011
Partner us in your efforts to market and sell your products leveraging our capabilities in one of Asia’s largest market. Talk to us to work together to increase the reach of our products. We would be happy to connect – email : sales_usa@krishgen.com info@krishgen.com Tel: +1-213-2913096 (US) +91-22-66372990 (India) Fax: +1-213-4022025 (US) +91-22-66372991 (India) A KRISHGEN PRESENTATION © 2011

More Related Content

About krishgen

  • 1. We Deliver More â„¢ Changing India’s biotech landscape by developing tools for the life sciences and agri industry D & B / SMERA Rated
  • 2. We are a single owner firm established in 2003, located in the commercial hub of India – Mumbai or erstwhile Bombay. KRISHGEN today operates in the broad segments of medical diagnostics, drug discovery research, biopharmaceuticals and plant / food sciences. The compounded average growth in the past three years has been 74% p.a. KRISHGEN gross revenues as of 2011 were USD5,0 million. A KRISHGEN PRESENTATION © 2011
  • 3. HOW TO USE THIS GUIDE: About KRISHGEN Targeting the research and diagnostics markets, our goal is to enable breakthroughs in biological research, diagnostics, drug discovery and the treatment of disease. We enjoy a dominant position in the provision of immunoassay kits, supply of primary human cells and cell lines, glycobiology and preclinical toxicology tools. KRISHGEN takes a highly collaborative approach to business relationships with its customers and partners. We are committed to providing our customers with world-class solutions, service and support. Our track record of delivering innovative new products, by distribution arrangements with leading companies worldwide or the judicious interface with the academia has given us the broadest range of products available. The strength lies in our ability to understand technologies and support the scientists with technical backup and strong logistics. A KRISHGEN PRESENTATION © 2011
  • 4. About KRISHGEN KRISHGEN meets the needs of its pharmaceutical and clinical customers by providing a range of Research Use Only kits for researchers in drug development and pre-clinical studies, and in offering fully-optimized and validated products for ensuing preclinical and clinical studies. KRISHGEN’s recently released cytokine ELISA kits are an innovative cost effective tool for disease research, drug discovery & development, and molecular diagnostic test development. KRISHGEN is funded privately through its owners and private investors. It is a non-listed, non-traded SME, rated by Dun & Bradstreet / SMERA (SME Rating Agency of India). Our DUNS Number is 65-039-6034. A KRISHGEN PRESENTATION © 2011
  • 5. Our History To support it's plans, Krishgen initially focused on developing marketing and distribution support for diagnostics. 2004.. First Partner for distribution tied-up with Medipan GmbH / Generic Assays GmbH in Germany. 2005 .. the research and life sciences products were introduced with its arrangements with leading US & European companies. 2006 .. the Glycobiology line was introduced in October for distribution. 2007 .. the tools for preclinical toxicology were introduced in August. 2008 .. Promocell GmbH, Germany distribution started in India. Its own products under the KRISHGEN label were manufactured and introduced in October. Krishgen started offering immunoassay development services in Nov 2008. 2009 .. KRIBIOLISA bioprocess ELISA kits launched. 2010 .. KRISHILISA GMO ELISA kits and Gold Ring Cytokine ELISAs launched. 2011 .. International distribution efforts started. KRISHGEN's product and service are now used by respected academic, biotech, pharmaceutical and government laboratories in India and worldwide. A KRISHGEN PRESENTATION © 2011
  • 6. KRISHGEN BIOSYSTEMS – Group Holding Proprietary Company Revenues* 2011 USD 5,0million Focuses on diagnostics, drug discovery research, plant / agri sciences and food safety Kodon Sciences KRISHTECH Solutions (India) Kodon Sciences (India) – focuses on plant sciences and food safety assays. Established in 2008. KRISHTECH Solutions – focuses on biopharmaceutical and vaccine manufacturing companies. Established in 2009. A KRISHGEN PRESENTATION © 2011
  • 7. Advisory Team Raman Jain, MSc (Northwestern University, US) Over 38 years experience in healthcare industry. Previously Managing Director, Nirlac Chemicals and then Fortex Remedies Pvt Ltd, contract manufacturer of sterile pharmaceuticals. Member : Indian Pharmaceutical Association. Founder Member Indian Drug (Pharmaceutical) Manufacturers Association Kawar Prashant Govindrao Scientist (PMB), Molecular Biology & Genetic Engineering Lab., Vasantdada Sugar Institute, Pune Dr I Khatkhatay Senior Scientist, National Institute For Research in Reproductive Health, Mumbai Dr Meena Desai Scientist, National Institute For Research in Reproductive Health, Mumbai Aditya Jain, MBA (Drexel University, USA) Vice President, LaReina Collection, Los Angeles, USA. A KRISHGEN PRESENTATION © 2011
  • 8. Investors / Source of Funds  Bank Of India  Owner’s Seed Capital Private Investors :  Veerchand Manawat Family  Kalpesh Jain HUF A KRISHGEN PRESENTATION © 2011
  • 9. Business Concept KRISHGEN believes in professionalism. Right from choosing principals which we have done with great care to our sales channel partners or our marketing team we have applied one principle – the approach and professionalism of the entity to the job at hand. We believe that a systematic approach and focus to the job will ensure that all set targets and goals are achieved. No fancy management jargons but a simple approach of doing the job given sincerely and keeping the customer happy. Our philosophy – We Deliver More – encompasses all that we believe in. A KRISHGEN PRESENTATION © 2011
  • 10. Our Sales Network We currently hold distribution rights for sales in South East Asia as well as in countries including Singapore, Malaysia, Thailand, Vietnam, Philippines for a number of our principal companies. Our focus the past few years has been in India which is our principal market and the major revenue earner. We reach the entire Indian region with our own employee based marketing field team supported by our product executives and application specialists. KRISHGEN also now has a network of distributors all across the world for its own manufactured / branded products. It also supplies on OEM labeling to leading US and Canadian based companies. A KRISHGEN PRESENTATION © 2011
  • 11. Technical Sales & Marketing Support  Regular Literatures and mailing on specific products and applications. (we use Constant Contact email marketing tool)  CD presentations on Product Category Focus  Training of Technicians / Users at our application laboratory  Participation in Trade Shows, Conferences, Exhibitions  Conducting Roadshows A KRISHGEN PRESENTATION © 2011
  • 12. Resources Library We have the largest resources library for marketing our products in terms of flyers, catalogs, brochures, technical series mails etc. Our in- house print shop has capacity to print and mail over 10,000 copies per month which we use in conjunction with our database. Promotions & Offers We conduct regular promotions and seasonal offers to boost sales and highlight products. A KRISHGEN PRESENTATION © 2011
  • 13. Markets and Achievements KRISHGEN today holds over 80% of the market for biopharmaceuticals with its glycosylation tools working with world’s leading companies. With our focus on costs and services, we are a `strategic vendor’ and ‘preferred partner’ to a number of leading biopharma and vaccine companies. We were the first movers to market exclusively Invitrogen’s primary human cell cultures and medias (erstwhile Cascade Biologics)in India from 2004 till 2008 when Invitrogen Corporation, USA set up it’s own subsidiary in India. We hold over 74% market share for the ADME Tox in India with our nearest competitor being BD Biosciences and Invitrogen. We are the market leaders in India for Vitamin D assays for medical diagnostics and for immunoassay tools for diabetes research and clinical studies. We have developed and now market exclusively our own manufactured bioprocess contamination kits for the Indian biopharmaceutical sector as well as a host of products. A KRISHGEN PRESENTATION © 2011
  • 14. Our Certifications We are registered with our Food & Drug Administration Ministry of Animal Husbandry Ministry of Health & Family Welfare Director-General of Foreign Trade Dun & Bradstreet / SMERA Our Association Memberships Member – Indian Merchant Chambers Member – Indo German Chamber of Commerce Member – Association of Biotechnology Led Enterprises Member - National Seed Association of India A KRISHGEN PRESENTATION © 2011
  • 15. Scientific Presentations Posters Presented - 2009 Immunocon, Bangalore Development and validation of a generic E.coli HCP ELISA for determination of host cell proteins for biopharmaceuticals expressed in E.coli 2010 Bangalore India Bio, Bangalore Development and validation of cost effective assay for Development and validation of ELISA for qualitative assessment of Cry 2Ab protein in Bt Cotton Development and analytical validation of a generic ELISA kit for measurement of Host Cell Proteins in Chinese Hamster Ovary cells. Use of indigenous ELISA for estimation of cytokines and estradiol levels in women A KRISHGEN PRESENTATION © 2011
  • 17. Our 3 E’s of Business which has enabled us to make KRISHGEN, India’s leading biotech company with products presence in Enthusiasm major markets across the world. Enterprise Energy A KRISHGEN PRESENTATION © 2011
  • 18. Partner us in your efforts to market and sell your products leveraging our capabilities in one of Asia’s largest market. Talk to us to work together to increase the reach of our products. We would be happy to connect – email : sales_usa@krishgen.com info@krishgen.com Tel: +1-213-2913096 (US) +91-22-66372990 (India) Fax: +1-213-4022025 (US) +91-22-66372991 (India) A KRISHGEN PRESENTATION © 2011

Editor's Notes